We are live on ! Find out more
SRC

Shufro Rose & Co Portfolio holdings

AUM $1.47B
1-Year Est. Return 19.38%
This Fund
S&P 500
This Quarter Est. Return
+5.37%
1 Year Est. Return
+19.38%
3 Year Est. Return
+47.49%
5 Year Est. Return
+55.37%
10 Year Est. Return
+200.77%
AUM
$1.02B
AUM Growth
+$21.3M
Cap. Flow
-$7.99M
Cap. Flow %
-0.79%
Top 10 Hldgs %
30.61%
Holding
299
New
42
Increased
39
Reduced
128
Closed
11

Top Buys

Rank Stock Value
1
SYF icon
Synchrony
SYF
+$4.93M
2
VTR icon
Ventas
VTR
+$4.73M
3
AR icon
Antero Resources
AR
+$3.4M
4
WELL icon
Welltower
WELL
+$2.7M
5
AGN
Allergan plc
AGN
+$2.69M

Top Sells

Rank Stock Value
1
TPH
Tri Pointe Homes
TPH
+$7.63M
2
GNTX icon
Gentex
GNTX
+$4.63M
3
ADNT icon
Adient
ADNT
+$3.64M
4
DNOW icon
DNOW Inc
DNOW
+$1.97M
5
AVY icon
Avery Dennison
AVY
+$1.88M

Sector Composition

Rank Sector Weight
1 Technology 23.34%
2 Industrials 14.37%
3 Financials 13.51%
4 Healthcare 13.29%
5 Consumer Discretionary 11.76%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KMB icon
201
Kimberly-Clark
KMB
$36.4B
$362K 0.04%
3,000
EFT
202
Eaton Vance Floating-Rate Income Trust
EFT
$283M
$361K 0.04%
+25,200
New +$363K
GILD icon
203
Gilead Sciences
GILD
$161B
$352K 0.03%
4,915
+15
+0.3% +$1.14K
AME icon
204
Ametek
AME
$55.5B
$350K 0.03%
4,824
-400
-8% -$27.9K
NTRS icon
205
Northern Trust
NTRS
$22.2B
$350K 0.03%
3,500
HSBC.PRA
206
DELISTED
HSBC Holdings PLC, Inc. ADS(1/40 shr. 6.2% Non-Cum. Dlr. Pref. Shrs., Ser.A)
HSBC.PRA
$349K 0.03%
13,525
+1,500
+12% +$39.1K
TIP icon
207
iShares TIPS Bond ETF
TIP
$14.5B
$346K 0.03%
3,033
+547
+22% +$62.2K
PSX icon
208
Phillips 66
PSX
$82.9B
$344K 0.03%
3,400
TEVA icon
209
Teva Pharmaceuticals
TEVA
$35.9B
$336K 0.03%
17,719
-8,225
-32% -$124K
AVX
210
DELISTED
AVX Corporation
AVX
$331K 0.03%
19,125
-20,200
-51% -$369K
MHN
211
DELISTED
BlackRock MuniHoldings New Yrok Quality Fund
MHN
$328K 0.03%
+24,500
New +$338K
AAL icon
212
American Airlines Group
AAL
$9.58B
$326K 0.03%
6,263
GSK icon
213
GSK
GSK
$103B
$318K 0.03%
7,182
+182
+3% +$8.41K
JEQ
214
DELISTED
abrdn Japan Equity Fund
JEQ
$317K 0.03%
+35,125
New +$322K
SVC
215
Service Properties Trust
SVC
$1.1B
$316K 0.03%
2,120
+60
+3% +$8.81K
KERX
216
DELISTED
Keryx Biopharmaceuticals Inc
KERX
$315K 0.03%
67,800
-2,600
-4% -$14.3K
HASI icon
217
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$4.9B
$311K 0.03%
+12,940
New +$310K
SNY icon
218
Sanofi
SNY
$104B
$310K 0.03%
7,200
UTF icon
219
Cohen & Steers Infrastructure Fund
UTF
$3.14B
$307K 0.03%
+12,800
New +$297K
USAP
220
DELISTED
Universal Stainless & Alloy
USAP
$304K 0.03%
14,197
CHS
221
DELISTED
Chicos FAS, Inc.
CHS
$302K 0.03%
34,200
-156,225
-82% -$1.3M
CAKE icon
222
Cheesecake Factory
CAKE
$4.21B
$301K 0.03%
+6,250
New +$284K
SABA
223
Saba Capital Income & Opportunities Fund II
SABA
$220M
$300K 0.03%
+23,250
New +$306K
EXC icon
224
Exelon
EXC
$48.6B
$298K 0.03%
10,585
-701
-6% -$20.1K
HON icon
225
Honeywell
HON
$77.1B
$296K 0.03%
2,137

Similar funds

Shufro Rose & Co's Q4 2017 Portfolio in Review

As of Q4 2017, Shufro Rose & Co held 299 positions worth $1.02B, up 2.1% from $995M the previous quarter. Its ten largest holdings account for 31% of the portfolio.

Shufro Rose & Co's Q4 2017 filing shows 42 new, 39 increased, 128 reduced and 11 closed positions. Its largest new stake was Ventas: 74,780 shares worth $4.49M. The largest sale was Tri Pointe Homes, an estimated $7.63M.

By sector, the portfolio is most concentrated in Technology at 23% of assets, up from 22% a quarter earlier, followed by Industrials and Financials.

  • Shufro Rose & Co's largest Q4 2017 buy was Ventas: 74,780 shares worth $4.49M.
  • Shufro Rose & Co added most to Synchrony in Q4 2017, an estimated $4.93M increase.
  • Shufro Rose & Co's biggest Q4 2017 reduction was Tri Pointe Homes, cutting an estimated $7.63M.
  • Shufro Rose & Co fully exited Gentex in Q4 2017, selling an estimated $4.63M.
  • Shufro Rose & Co's ten largest holdings make up 31% of its $1.02B portfolio in Q4 2017.
  • Shufro Rose & Co opened 42 new positions and closed 11 in Q4 2017.
  • Shufro Rose & Co's portfolio value rose 2.1% quarter-over-quarter to $1.02B.

Based on Shufro Rose & Co's 13F filing for Q4 2017, filed 6 Feb 2018.